Location History:
- Seattle, WA (US) (2010 - 2013)
- Boston, MA (US) (2016)
Company Filing History:
3 out of 1,209 
1 out of 505 
Years Active: 2010-2016
Title: The Innovations of Toshiyasu Taniguchi
Introduction
Toshiyasu Taniguchi is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer susceptibilities and defective DNA repair mechanisms. With a total of 3 patents, his work has paved the way for advancements in genetic-based tests and therapeutic agents.
Latest Patents
Taniguchi's latest patents include methods and compositions for diagnosing cancer susceptibilities and defective DNA repair mechanisms. These innovations provide essential tools for screening patients and diagnosing conditions such as Fanconi Anemia and cancer. His research has identified the FANCD2 gene, which can be targeted in vivo to prepare experimental mouse models for screening new therapeutic agents. Additionally, he has developed methods and compositions for treating cancer, focusing on inhibitors of the Fanconi anemia pathway that can inhibit DNA damage repair.
Career Highlights
Throughout his career, Taniguchi has worked with esteemed institutions such as Dana-Farber Cancer Institute Inc. and Oregon Health & Science University. His research has significantly impacted the understanding of cancer biology and the development of targeted therapies.
Collaborations
Taniguchi has collaborated with notable colleagues, including Alan D D'Andrea and Edward A Fox. These partnerships have further enhanced the scope and impact of his research in the field of cancer treatment.
Conclusion
Toshiyasu Taniguchi's contributions to cancer research through his innovative patents and collaborations have established him as a key figure in the scientific community. His work continues to influence the development of diagnostic and therapeutic strategies for cancer treatment.